← Eichor
Study identifier: NCT06165991 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Liposomal and Standard Bupivacaine in Thoracic Paravertebral Block for Post-Thoracoscopic Pain

Condition: Thoracic Paravertebral Block · Postoperative Analgesia · Thoracoscopic Lobectomy  ·  Sponsor: Yongtao Sun

PhasePhase 4
Planned participants496
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

I. Research purpose 1.1 Main Objective: To investigate the efficacy and safety of bupivacaine liposome thoracic paravertebral nerve block for postoperative analgesia after thoracoscopic lobectomy 1.2 Exploratory Objective: To investigate the noninferiority of bupivacaine liposomes in thoracic paravertebral nerve block with standard bupivacaine

This description comes directly from the study's public registry record.

Talk to the study team

yong t Sun, PH.D  ·  18660795201  ·  sunyongtao1979@163.com

jian bo Wu, PH.D  ·  18560083793  ·  jianbowu@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Qianfoshan Hospital, The First Hospital affiliated of Shandong First Medical UniversityJinan, Shandong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06165991